EP1037601A2 - Liquid composition with enhanced low temperature stability - Google Patents

Liquid composition with enhanced low temperature stability

Info

Publication number
EP1037601A2
EP1037601A2 EP98966317A EP98966317A EP1037601A2 EP 1037601 A2 EP1037601 A2 EP 1037601A2 EP 98966317 A EP98966317 A EP 98966317A EP 98966317 A EP98966317 A EP 98966317A EP 1037601 A2 EP1037601 A2 EP 1037601A2
Authority
EP
European Patent Office
Prior art keywords
viscosity
composition according
fatty acid
composition
emulsifier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP98966317A
Other languages
German (de)
French (fr)
Other versions
EP1037601B1 (en
Inventor
Virgilio Babra Villa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever PLC
Unilever NV
Original Assignee
Unilever PLC
Hindustan Lever Ltd
Unilever NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25539617&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP1037601(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Unilever PLC, Hindustan Lever Ltd, Unilever NV filed Critical Unilever PLC
Publication of EP1037601A2 publication Critical patent/EP1037601A2/en
Application granted granted Critical
Publication of EP1037601B1 publication Critical patent/EP1037601B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0295Liquid crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations

Definitions

  • the present invention relates to liquid cleansing compositions of the type typically used in skin cleansing or shower gel compositions, which compositions are lamellar phase compositions.
  • Such lamellar compositions are characterized by high zero shear viscosity (i.e. good for suspending) whilst simultaneously being very shear thinning, such that they readily dispense in pouring.
  • spherical, cylindrical (rod-like) or discoidal micelles may form.
  • ordered liquid crystalline phases such as lamellar phase, hexagonal phase or cubic phase may form.
  • the lamellar phase for example, consists of alternating surfactant bilayers and water layers. These layers are not generally flat but fold to form submicron spherical onion like structures called vesicles or liposomes.
  • the hexagonal phase on the other hand, consists of long cylindrical micelles arranged in a hexagonal lattice.
  • the microstructure of most personal care products consist of either spherical micelles, rod micelles, or a lamellar dispersion.
  • micelles may be spherical or rod-like.
  • Formulations having spherical micelles tend to have a low viscosity and exhibit Newtonian shear behavior (i.e., the viscosity stays constant as a function of shear rate; thus, if easy pouring of product is desired, the solution is less viscous and, as a consequence, it doesn't suspend as well) .
  • the viscosity increases linearly with surfactant concentration.
  • Rod micellar solutions are more viscous because movement of the longer micelles is restricted. At a critical shear rate, the micelles align, and the solution becomes shear thinning. Addition of salts increases the size of the rod micelles thereby increasing zero shear viscosity (i.e., the viscosity when sitting in a bottle) which helps suspend particles, but also increases critical shear rate (i.e. the point at which the product becomes shear thinning; higher critical shear rates mean the product is more difficult to pour) .
  • zero shear viscosity i.e., the viscosity when sitting in a bottle
  • critical shear rate i.e. the point at which the product becomes shear thinning; higher critical shear rates mean the product is more difficult to pour
  • Lamellar dispersions differ from both spherical and rod-like micelles because they can have high zero shear viscosity (because of the close packed arrangement of constituent lamellar droplets) , yet these solutions are very shear thinning (i.e. they readily dispense on pouring) . That is, the solutions can become thinner than rod micellar solutions at moderate shear rates.
  • liquid cleansing compositions therefore, there is the choice of using rod-micellar solutions (whose zero shear viscosity, e.g., suspending ability, is not very good and/or are not very shear thinning) , or lamellar dispersions (with higher zero shear viscosity, i.e. they are better suspending, and yet are very shear thinning) .
  • rod-micellar solutions whose zero shear viscosity, e.g., suspending ability, is not very good and/or are not very shear thinning
  • lamellar dispersions with higher zero shear viscosity, i.e. they are better suspending, and yet are very shear thinning
  • lamellar compositions are generally more desirable (especially for suspending emollient, and for providing consumer aesthetics) , but more expensive in that they generally require more surfactant, and are more restricted in the range of surfactants that can be used.
  • rod-micellar solutions When rod-micellar solutions are used, they also often require the use of external structurants to enhance viscosity and to suspend particles (again, because they have lower zero shear viscosity than lamellar phase solutions) . For this, carbomers and clays are often used. At higher shear rates (i.e. as in product dispensing, application of the product to the body, or rubbing between the hands) , since the rod-micellar solutions are less shear thinning, the viscosity of the solution stays high, and the product can be stringy and thick. Lamellar dispersion based products, having higher zero shear viscosity, can more readily suspend emollients, and are typically more creamy.
  • lamellar phase compositions are easy to identify by their characteristic focal conic shape and oily streak texture, whilst hexagonal phase compositions exhibit angular, fan-like texture. In contrast, micellar phases are optically isotropic.
  • lamellar phases may be formed in a wide variety of surfactant systems using a wide variety of lamellar phase "inducers", as described, for example, in applicants co-pending application, U.S. Serial No. 08/789,726 to Puwada et al .
  • the transition from micelle to lamellar phase are functions of effective average area of headgroup of the surfactant, the length of the extended tail, and the volume of tail.
  • branched surfactants or surfactants with smaller headgroups or bulky tails are all effective ways of inducing transitions from rod micellar to lamellar.
  • One way of characterizing lamellar dispersions include measuring viscosity at low shear rate (using for example a Stress Rheometer) when additional inducer (e.g., oleic acid or isostearic acid) is used. At higher amounts of inducer, the low shear viscosity will significantly increase.
  • inducer e.g., oleic acid or isostearic acid
  • Micrographs generally will show lamellar microstructure and close packed organization of the lamellar droplets (generally in size range of about 2 microns) .
  • lamellar phase compositions tend to lose their lamellar stability in colder temperatures (e.g., -18°C to 7°C(0 to 45F) ) . While not wishing to be bound by theory, this may be because, in cold conditions, the oil droplets become less flexible, and the spherical structure characterizing the lamellar interaction breaks into lamellar sheets instead.
  • polymeric emulsifiers particularly hydrophilic groups modified on one or both ends, preferably both ends, by polyhydroxy fatty acid ester hydrophobic chains (e.g., dipolyhydroxystearate)
  • polyhydroxy fatty acid ester hydrophobic chains e.g., dipolyhydroxystearate
  • the invention comprises a liquid cleansing composition comprising:
  • At least one anionic surfactant or a mixture of anionic surfactants e.g., 0.5 to 25% by wt .
  • anionic surfactant e.g., 0.5 to 25% by wt .
  • amphoteric and/or zwitterionic surfactant e.g., betaine
  • mixtures thereof e.g., 0.1 to 25% by wt .
  • 0.1% to 15% by wt . preferably 1% to 10% by wt . of a lamellar phase inducing structurant selected from the group consisting of :
  • compositions have an initial viscosity of greater than, 40,000 cps measured at 0.5 RPM using T-bar spindle A, preferably greater than 75,000 cps, more preferably from about 90,000 to about 150,000 cps, and a freeze thaw viscosity (measured after at least one cycle, preferably at least 2 cycles, most preferably at 3 cycles of -9.4°C (15F) to room temperature freeze thaw cycles) at greater than about 40,000 cps, preferably greater than 50,000 (again measured at 0.5 RPM using T-bar spindle A) .
  • there should be no change in viscosity from initial viscosity although this of course is not always
  • Particularly preferred emulsifiers comprise a polyalkylene glycol backbone and have 1 to 50 hydroxy Cg to
  • Figure 1 shows effect of the polymeric hydrophilic emulsifier of invention when used in combination with lamellar phase inducing structurant.
  • the emulsifier enhances both initial and freeze-thaw viscosity compared to use of structurant with no emulsifier.
  • Figure 2 shows that, for a given level of lamellar inducing structurant (e.g., isostearic acid at 5%), use of emulsifier (e.g., Arlacel P135) has no significant negative impact on lather production.
  • lamellar inducing structurant e.g., isostearic acid at 5%
  • emulsifier e.g., Arlacel P1305
  • Figure 3A and 3B shows that, although it is possible to improve initial and freeze-thaw viscosity by increasing level of isostearic acid, for example, in combination with 0.5% Arlacel P135 (Figure 3A) , the additional isostearic acid added to constant small level of Arlacel P135 will negatively impact on lather volume ( Figure 3B) . Therefore, to improve both stability without effecting lather volume, the focus should be on using emulsifier rather than increasing lamellar inducing structurant.
  • Figure 4 is a schematic structure of a typical polymeric emulsifier, PEG-30 dipolyhydroxystearate.
  • the present invention relates to liquid cleansing compositions, particularly lamellar structured liquid cleansing compositions comprising:
  • a surfactant system comprising one or more anionic surfactants and preferably further comprising an amphoteric and/or zwitterionic surfactant or mixtures thereof;
  • a lamellar phase inducing structurant which can be selected form the group consisting of:
  • composition e.g., mono or dipolyhydroxy, C8-C2 fatty acid esters, such as, for example dipolyhydroxystearate
  • the composition has an initial viscosity of greater than 40,000 cps, preferably 90,000 to 130,000 cps; and a freeze thaw viscosity of greater than 40,000 cps, preferably greater than
  • the surfactant system of the subject invention comprises 5 to 50% by weight, preferably 10 to 40% by wt . of the composition and comprises : (a) one or more anionic surfactants;
  • the anionic surfactant may be, for example, an aliphatic sulfonate, such as a primary alkane (e.g., C 8 -C22) sulfonate, primary alkane (e.g., C 8 -C 2) disulfonate, C 8 -C 2 2 alkene sulfonate, C 8 -C22 hydroxyalkane sulfonate or alkyl glyceryl ether sulfonate (AGS) ; or an aromatic sulfonate such as alkyl benzene sulfonate.
  • a primary alkane e.g., C 8 -C22
  • primary alkane e.g., C 8 -C 2
  • disulfonate C 8 -C 2 2 alkene sulfonate
  • C 8 -C22 hydroxyalkane sulfonate C 8 -C22 hydroxyalkane sulfonate or
  • the anionic may also be an alkyl sulfate (e.g., C ⁇ - ⁇ alkyl sulfate) or alkyl ether sulfate (including alkyl glyceryl ether sulfates) .
  • alkyl ether sulfates are those having the formula:
  • R is an alkyl or alkenyl having 8 to 18 carbons, preferably 12 to 18 carbons, n has an average value of greater than 1.0, preferably between 2 and 3; and M is a solubilizing cation such as sodium, potassium, ammonium or substituted ammonium. Ammonium and sodium lauryl ether sulfates are preferred.
  • the anionic may also be alkyl sulfosuccinates
  • alkyl and acyl taurates including mono- and dialkyl, e.g., Cg-C 2 2 sulfosuccinates
  • alkyl and acyl taurates including mono- and dialkyl, e.g., Cg-C 2 2 sulfosuccinates
  • alkyl and acyl taurates including mono- and dialkyl, e.g., Cg-C 2 2 2 sulfosuccinates
  • alkyl and acyl taurates including mono- and dialkyl, e.g., Cg-C 2 2 sulfosuccinates
  • alkyl and acyl taurates including alkyl and acyl taurates, alkyl and acyl sarcosinates, sulfoacetates, C 8 -C 22 alkyl phosphates and phosphates, alkyl phosphate esters and alkoxyl alkyl phosphate esters, acy
  • Sulfosuccinates may be monoalkyl sulfosuccinates having the formula:
  • amido-MEA sulfosuccinates of the formula
  • R ranges from C 8 -C 22 alkyl and M is a solubilizing cation
  • alkoxylated citrate sulfosuccinates alkoxylated citrate sulfosuccinates
  • alkoxylated sulfosuccinates such as the following:
  • Taurates are generally identified by formula
  • R ranges from C 8 -C o alkyl, R ranges from Ci-
  • C 4 alkyl and M is a solubilizing cation.
  • Another class of anionics are carboxylates such as follows :
  • R is C 8 to C 20 alkyl; n is 0 to 20; and M is as defined above.
  • amido alkyl polypeptide carboxylates such as, for example, Monteine
  • C 8 -C ⁇ 8 acyl isethionates Another surfactant which may be used are the C 8 -C ⁇ 8 acyl isethionates . These esters are prepared by reaction between alkali metal isethionate with mixed aliphatic fatty acids having from 6 to 18 carbon atoms and an iodine value of less than 20. At least 75% of the mixed fatty acids have from 12 to 18 carbon atoms and up to 25% have from 6 to 10 carbon atoms .
  • Acyl isethionates when present, will generally range from about 0.5-15% by weight of the total composition.
  • this component is present from about 1 to about 10%.
  • the acyl isethionate may be an alkoxylated isethionate such as is described in Ilardi et al . , U.S. Patent No.
  • R is an alkyl group having 8 to 18 carbons
  • m is an integer from 1 to 4
  • X and Y are hydrogen or an alkyl group having 1 to 4 carbons
  • M is a monovalent cation such as, for example, sodium, potassium or ammonium.
  • the anionic component will comprise from about 1 to 20% by weight of the composition, preferably 2 to 15%, most preferably 5 to 12% by weight of the composition.
  • Suitable zwitterionic surfactants are exemplified by those which can be broadly described as derivatives of aliphatic quaternary ammonium, phosphonium, and sulfonium compounds, in which the aliphatic radicals can be straight or branched chain, and wherein one of the aliphatic substituents contains from about 8 to about 18 carbon atoms and one contains an anionic group, e.g., carboxy, sulfonate, sulfate, phosphate, or phosphonate.
  • a general formula for these compounds is:
  • R 2 -Y (+) -CH 2 -R 4 Z ) 2 wherein R contains an alkyl, alkenyl, or hydroxy alkyl radical of from about 8 to about 18 carbon atoms, from 0 to about 10 ethylene oxide moieties and from 0 to about 1 glyceryl moieties; Y is selected from nitrogen, phosphorus,
  • R is an alkyl or monohydroxyalkyl group containing about 1 to about 3 carbon atoms
  • X is 1 when Y is a sulfur atom, and 2 when Y is a nitrogen or phosphorus
  • R is an alkylene or hydroxyalkylene of from about 1 to about 4 carbon atoms and Z is a radical selected from carboxylate, sulfonate, sulfate, phosphonate, and phosphate groups .
  • surfactants include: 4- [N,N-di (2 -hydroxyethyl) -N-octadecylammonio] -butane-1- carboxylate;
  • Suitable amphoteric detergents which may be used in this invention include at least one acid group. This may be a carboxylic or a sulphonic acid group. They include quaternary nitrogen and therefore are quaternary amido acids. They should generally include an alkyl or alkenyl group of 7 to 18 carbon atoms. They will usually comply with an overall structural formula:
  • R is alkyl or alkenyl of 7 to 18 carbon atoms
  • R and R are each independently alkyl, hydroxyalkyl or carboxyalkyl of 1 to 3 carbon atoms;
  • n 2 to 4;
  • n 0 to 1;
  • X is alkylene of 1 to 3 carbon atoms optionally substituted with hydroxyl
  • Suitable amphoteric detergents within the above general formula include simple betaines of formula:
  • R may in particular be a mixture of C 12 and C ⁇ alkyl groups derived from coconut so that at least half, preferably at least three quarters of the groups R have 10
  • R and R are preferably methyl.
  • amphoteric detergent is a sulphobetaine of formula: R '
  • Amphoacetates and diamphoacetates are also intended to be covered in possible zwitterionic and/or amphoteric compounds which may be used.
  • amphoteric/zwitterionic surfactant when used, generally comprises 0% to 25%, preferably 0.1 to 20% by weight, preferably 5% to 15% of the composition.
  • a preferred surfactant system of the invention comprises acyl isethionate in combination with betaine (e.g., cocoamido propylbetaine) .
  • the surfactant system may optionally comprise a nonionic surfactant .
  • the nonionic which may be used includes in particular the reaction products of compounds having a hydrophobic group and a reactive hydrogen atom, for example aliphatic alcohols, acids, amides or alkyl phenols with alkylene oxides, especially ethylene oxide either alone or with propylene oxide.
  • Specific nonionic detergent compounds are alkyl (Cg-C 22 ) phenols-ethylene oxide condensates, the condensation products of aliphatic (C 8 -C]_ 8 ) primary or secondary linear or branched alcohols with ethylene oxide, and products made by condensation of ethylene oxide with the reaction products of propylene oxide and ethylenediamine .
  • Other so-called nonionic detergent compounds include long chain tertiary amine oxides, long chain tertiary phosphine oxides and dialkyl sulphoxides .
  • the nonionic may also be a sugar amide, such as a polysaccharide amide.
  • the surfactant may be one of the lactobionamides described in U.S. Patent No. 5,389,279 to Au et al . which is hereby incorporated by reference or it may be one of the sugar amides described in Patent No. 5,009,814 to Kelkenberg, hereby incorporated into the subject application by reference.
  • alkyl polysaccharides are alkylpolyglycosides of the formula
  • R is selected from the group consisting of alkyl , alkylphenyl , hydroxyalkyl , hydroxyalkylphenyl , and mixtures thereof in which alkyl groups contain from about 10 to about 18, preferably from about 12 to about 14, carbon atoms; n is 0 to 3, preferably 2; t is from 0 to about 10, preferably 0; and x is from 1.3 to about 10, preferably from 1.3 to about 2.7.
  • the glycosyl is preferably derived from glucose. To prepare these compounds, the alcohol or alkylpolyethoxy alcohol is formed first and then reacted with glucose, or a source of glucose, to form the glucoside (attachment at the 1-position) . The additional glycosyl units can then be attached between their 1 -position and the preceding glycosyl units 2-, 3-, 4- and/or 6 -position, preferably predominantly the 2 -position.
  • Nonionic surfactant typically comprises 0 to 10% by wt . of the composition.
  • the present invention provides compositions utilizing about 0.1% to 15% by wt . , preferably 1 to 10% by wt . of a structuring agent which works in the compositions to form a lamellar phase.
  • a structuring agent which works in the compositions to form a lamellar phase.
  • Such lamellar phase is preferred because it enables the compositions to suspend particles more readily (e.g., emollient particles) while still maintaining good shear thinning properties.
  • the lamellar phase also provides consumers with desired rheology ("heaping").
  • composition is not lamellar structured and enhanced particle suspension/enhancing is desired, it is usually necessary to add external structurants such as carbomers (e.g., cross- linked polyacrylate such as Carbopol (R) ) and clays.
  • external structurants such as carbomers (e.g., cross- linked polyacrylate such as Carbopol (R) ) and clays.
  • carbomers e.g., cross- linked polyacrylate such as Carbopol (R)
  • R Carbopol
  • these external structurants have poorer shear thinning properties that significantly reduce consumer acceptability.
  • the structurant is generally an unsaturated and/or branched long chain (C 8 -C 24 ) liquid fatty acid or ester derivative thereof; and/or unsaturated and/or branched long chain liquid alcohol or ether derivatives thereof. It may also be a short chain saturated fatty acid such as capric acid or caprylic acid. While not wishing to be bound by theory, it is believed that the unsaturated part of the fatty acid of alcohol or the branched part of the fatty acid or alcohol acts to "disorder" the surfactant hydrophobic chains and induce formation of lamellar phase.
  • liquid fatty acids which may be used are oleic acid, isostearic acid, linoleic acid, linolenic acid, ricinoleic acid, elaidic acid, arichidonic acid, myristoleic acid and palmitoleic acid.
  • Ester derivatives include propylene glycol isostearate, propylene glycol oleate, glyceryl isostearate, glyceryl oleate and polyglyceryl diisostearate .
  • alcohols include oleyl alcohol and isostearyl alcohol .
  • ether derivatives include isosteareth or oleth carboxylic acid; or isosteareth or oleth alcohol .
  • the structuring agent may be defined as having melting point below about 25°C centigrade.
  • the key to the invention is the discovery that use of relatively small amounts of hydrophilic emulsifier modified at one or both ends, preferably both ends, with hydrophobic polyhydroxy fatty acid ester chains can remarkably enhance both initial viscosity/stability as well as freeze-thaw stability of the composition. Further, it does so without sacrificing lather production.
  • use of as little as 0.1%, preferably 0.25% of the emulsifier enhances viscosity of the composition relative to compositions which contain lamellar inducing structurant, but do not additionally contain the emulsifier.
  • the emulsifier may comprise a polyalkylene glycol backbone chain (e.g., H (OCH 2 CH 2 ) n 0H) wherein n ranges from 2 to 60.
  • the polyalkylene glycol backbone unit is a C 2 -C 4 alkylene glycol such as ethylene or propylene glycol.
  • One or both ends, preferably both, of the polyalkylene glycol backbone are modified with attached polyhydroxy fatty acid C 8 to C 2 , preferably C 12 to C 20 esters such as, for example, polyhydroxystearate .
  • the hydrophobic group might be as follows: [CH 3 ( CH 2 ) 5 CH ( CH 2 ) I OCOOH] ⁇ ;
  • i may vary from 1 to 50.
  • Figure 4 provides a schematic structure of a typical emulsifier which might be used having a polyalkylene glycol backbone as noted above and modified at both ends with hydrophobic groups (e.g., polyhydroxystearate) wherein number of groups at each end could vary from 1 to 50.
  • hydrophobic groups e.g., polyhydroxystearate
  • PEG-30 dipolyhydroxystearate which is also known under the tradename Arlacel P135 (R) ex ICI .
  • R Arlacel P135
  • the number of repeating alkylene groups on the chain could vary from 2 to 60 and attached hydrophobic groups may be other polyhydroxy fatty acid esters, wherein the number of groups at each end varies from 1 to 50.
  • a particularly good combination of the invention providing enhanced initial and freeze-thaw viscosity comprises use of isostearic acid in combination with PEG-30 dipolyhydroxystearate.
  • the initial viscosity is about 40,000 cps, but when subjected to freeze-thaw tests when temperature is lowered (i.e., to be about -9.4°C(15F)) and raised (i.e., to room temperature), the viscosity remains the same or lower.
  • emulsifier e.g., 0.25%
  • both initial viscosity and freeze- thaw viscosity are enhanced.
  • One of the principle benefits of the invention is the ability to suspend oil/emollient particles in a lamellar phase composition.
  • the following oils/emollients may optionally be suspended in the compositions of the invention.
  • Various classes of oils are set forth below.
  • Vegetable oils Arachis oil, castor oil, cocoa butter, coconut oil, corn oil, cotton seed oil, olive oil, palm kernel oil, rapeseed oil, safflower seed oil, sesame seed oil and soybean oil .
  • Esters Butyl myristate, cetyl palmitate, decyloleate, glyceryl laurate, glyceryl ricinoleate, glyceryl stearate, glyceryl isostearate, hexyl laurate, isobutyl palmitate, isocetyl stearate, isopropyl isostearate, isopropyl laurate, isopropyl linoleate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, propylene glycol monolaurate, propylene glycol ricinoleate, propylene glycol stearate, and propylene glycol isostearate.
  • Fatty acids and alcohols Behenic acid, palmitic acid, stearic acid, behenyl alcohol, cetyl alcohol, eicosanyl alcohol and isocetyl alcohol.
  • oils/emollients include mineral oil, petrolatum, silicone oil such as dimethyl polysiloxane, lauryl and myristyl lactate.
  • the emollient may also function as a structurant, it should not be doubly included such that, for example, if the structurant is 15% oleyl alcohol, no more than 5% oleyl alcohol as "emollient” would be added since the emollient (whether functioning as emollient or structurant) never comprises more than 20%, preferably no more than 15% of the composition.
  • the emollient/oil is generally used in an amount from about 1 to 20%, preferably 1 to 15% by wt . of the composition. Generally, it should comprise no more than 20% of the composition.
  • compositions of the invention may include optional ingredients as follows:
  • Organic solvents such as ethanol ; auxiliary thickeners, such as carboxymethylcellulose, magnesium aluminum silicate, hydroxyethylcellulose, methylcellulose, carbopols, glucamides, or Antil (R) from Rhone Poulenc; perfumes; sequestering agents, such as tetrasodium ethylenediaminetetraacetate (EDTA) , EHDP or mixtures in an amount of 0.01 to 1%, preferably 0.01 to 0.05%; and coloring agents, opacifiers and pearlizers such as zinc stearate, magnesium stearate, Ti0 2 , EGMS (ethylene glycol monostearate) or Lytron 621 (Styrene/Acrylate copolymer) ; all of which are useful in enhancing the appearance or cosmetic properties of the product.
  • auxiliary thickeners such as carboxymethylcellulose, magnesium aluminum silicate, hydroxyethylcellulose, methylcellulose, carbopols, glucamides, or Antil (R) from
  • compositions may further comprise antimicrobials such as 2-hydroxy-4 , 2 ' 4 ' trichlorodiphenylether (DP300) ; preservatives such as dimethyloldimethylhydantoin (Glydant XL1000TM) , parabens, sorbic acid, and so on.
  • antimicrobials such as 2-hydroxy-4 , 2 ' 4 ' trichlorodiphenylether (DP300)
  • preservatives such as dimethyloldimethylhydantoin (Glydant XL1000TM) , parabens, sorbic acid, and so on.
  • compositions may also comprise coconut acyl mono- or diethanol amides as suds boosters, and strongly ionizing salts such as sodium chloride and sodium sulfate may also be used to advantage.
  • Antioxidants such as, for example, butylated hydroxytoluene (BHT) may be used advantageously in amounts of about 0.01% or higher if appropriate.
  • BHT butylated hydroxytoluene
  • Cationic conditioners which may be used include Quatrisoft LM-200 Polyquaternium-24 , Merquat Plus 3330 Polyquaternium 39; and Jaguar (R) type conditioners.
  • Polyethylene glycols which may be used include:
  • Thickeners which may be used include Amerchol Polymer
  • HM 1500 Nonoxynyl Hydroethyl Cellulose
  • Glucam DOE 120 PEG 120 Methyl Glucose Dioleate
  • Rewoderm (R) PEG modified glyceryl cocoate, palmate or tallowate
  • Antil (R) 141 from Goldschmidt
  • Another optional ingredient which may be added are the deflocculating polymers such as are taught in U.S. Patent No. 5,147,576 to Montague, hereby incorporated by reference.
  • exfoliants such as polyoxyethylene beads, walnut sheets and apricot seeds
  • Viscosity measurements were made in accordance with the following protocol .
  • This method covers the measurement of the viscosity of the finished product. It is used to measure the degree of structuring of the product .
  • Plastic cups diameter greater than 6.35cm (2.5 inches).
  • compositions comprising base, oil, Arlacel P135 and isostearic acid as noted below and obtained viscosity results at both normal (room temperature) and accelerated conditions as follows:
  • compositions comprising varying levels of active (PEG-30 dipolyhydroxystearate) and isostearic acid.
  • active PEG-30 dipolyhydroxystearate
  • isostearic acid either levels of emulsifier or lamellar inducing structurant can be varied although preferably it is level of emulsifier which is varied to ensure foam volume is maintained.
  • initial viscosity and freeze-thaw viscosity can be improved by addition of lamellar inducing structurant (e.g. isostearic acid), in combination with polyethylene glycol for example, ( Figure 3A) , if it is added to a constant small level of emulsifier, lather volume is effected ( Figure 3B) .
  • lamellar inducing structurant e.g. isostearic acid
  • focus is on using more emulsifier rather than just increasing lamellar inducing structurant.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)

Abstract

The invention relates to liquid cleansing compositions in lamellar phase. Use of minimum amounts of defined polymeric hydrophilic emulsifier in combination with a lamellar phase inducing structurant has been found to enhance both initial viscosity and free thaw (low temperature) viscosity/stability.

Description

LIQUID COMPOSITION WITH ENHANCED LOW TEMPERATURE STABILITY
The present invention relates to liquid cleansing compositions of the type typically used in skin cleansing or shower gel compositions, which compositions are lamellar phase compositions. Such lamellar compositions are characterized by high zero shear viscosity (i.e. good for suspending) whilst simultaneously being very shear thinning, such that they readily dispense in pouring.
The rheological behavior of all surfactant solutions, including liquid cleansing solutions, is strongly dependent on the microstructure, i.e., the shape and concentration of micelles or other self-assembled structures in solution.
When there is sufficient surfactant to form micelles (i.e. the concentrations are above the critical micelle concentration or CMC), for example spherical, cylindrical (rod-like) or discoidal micelles may form. As the surfactant concentration increases, ordered liquid crystalline phases such as lamellar phase, hexagonal phase or cubic phase may form. The lamellar phase, for example, consists of alternating surfactant bilayers and water layers. These layers are not generally flat but fold to form submicron spherical onion like structures called vesicles or liposomes. The hexagonal phase, on the other hand, consists of long cylindrical micelles arranged in a hexagonal lattice. In general, the microstructure of most personal care products consist of either spherical micelles, rod micelles, or a lamellar dispersion.
As noted above, micelles may be spherical or rod-like. Formulations having spherical micelles tend to have a low viscosity and exhibit Newtonian shear behavior (i.e., the viscosity stays constant as a function of shear rate; thus, if easy pouring of product is desired, the solution is less viscous and, as a consequence, it doesn't suspend as well) . In these systems, the viscosity increases linearly with surfactant concentration.
Rod micellar solutions are more viscous because movement of the longer micelles is restricted. At a critical shear rate, the micelles align, and the solution becomes shear thinning. Addition of salts increases the size of the rod micelles thereby increasing zero shear viscosity (i.e., the viscosity when sitting in a bottle) which helps suspend particles, but also increases critical shear rate (i.e. the point at which the product becomes shear thinning; higher critical shear rates mean the product is more difficult to pour) .
Lamellar dispersions differ from both spherical and rod-like micelles because they can have high zero shear viscosity (because of the close packed arrangement of constituent lamellar droplets) , yet these solutions are very shear thinning (i.e. they readily dispense on pouring) . That is, the solutions can become thinner than rod micellar solutions at moderate shear rates.
In formulating liquid cleansing compositions, therefore, there is the choice of using rod-micellar solutions (whose zero shear viscosity, e.g., suspending ability, is not very good and/or are not very shear thinning) , or lamellar dispersions (with higher zero shear viscosity, i.e. they are better suspending, and yet are very shear thinning) . To form such lamellar compositions, however, some compromises have to be made. First, generally higher amounts of surfactant are required to form the lamellar phase. Thus, it is often needed to add auxiliary surfactants and/or salts, which are neither desirable nor needed. Secondly, only certain surfactants will form this phase and, therefore, the choice of surfactants is restricted.
In short, lamellar compositions are generally more desirable (especially for suspending emollient, and for providing consumer aesthetics) , but more expensive in that they generally require more surfactant, and are more restricted in the range of surfactants that can be used.
When rod-micellar solutions are used, they also often require the use of external structurants to enhance viscosity and to suspend particles (again, because they have lower zero shear viscosity than lamellar phase solutions) . For this, carbomers and clays are often used. At higher shear rates (i.e. as in product dispensing, application of the product to the body, or rubbing between the hands) , since the rod-micellar solutions are less shear thinning, the viscosity of the solution stays high, and the product can be stringy and thick. Lamellar dispersion based products, having higher zero shear viscosity, can more readily suspend emollients, and are typically more creamy. Again, however, they are generally more expensive to make (e.g., they are restricted as to which surfactants can be used, and often require greater concentration of surfactants) . In general, lamellar phase compositions are easy to identify by their characteristic focal conic shape and oily streak texture, whilst hexagonal phase compositions exhibit angular, fan-like texture. In contrast, micellar phases are optically isotropic.
In should be understood that lamellar phases may be formed in a wide variety of surfactant systems using a wide variety of lamellar phase "inducers", as described, for example, in applicants co-pending application, U.S. Serial No. 08/789,726 to Puwada et al . Generally, the transition from micelle to lamellar phase are functions of effective average area of headgroup of the surfactant, the length of the extended tail, and the volume of tail. Using branched surfactants or surfactants with smaller headgroups or bulky tails are all effective ways of inducing transitions from rod micellar to lamellar.
One way of characterizing lamellar dispersions include measuring viscosity at low shear rate (using for example a Stress Rheometer) when additional inducer (e.g., oleic acid or isostearic acid) is used. At higher amounts of inducer, the low shear viscosity will significantly increase.
Another way of measuring lamellar dispersions is using freeze fracture electron microscopy. Micrographs generally will show lamellar microstructure and close packed organization of the lamellar droplets (generally in size range of about 2 microns) .
One problem with certain lamellar phase compositions is that they tend to lose their lamellar stability in colder temperatures (e.g., -18°C to 7°C(0 to 45F) ) . While not wishing to be bound by theory, this may be because, in cold conditions, the oil droplets become less flexible, and the spherical structure characterizing the lamellar interaction breaks into lamellar sheets instead.
Unexpectedly, the applicants have now found that certain polymeric emulsifiers, particularly hydrophilic groups modified on one or both ends, preferably both ends, by polyhydroxy fatty acid ester hydrophobic chains (e.g., dipolyhydroxystearate) , can be used at small levels to enhance both initial viscosity and low temperature viscosity, thereby providing much more stable compositions.
In a first aspect, the invention comprises a liquid cleansing composition comprising:
(a) 5% to 50% by wt . of a surfactant system comprising :
(i) at least one anionic surfactant or a mixture of anionic surfactants (e.g., 0.5 to 25% by wt . ) ; and (ii) preferably an amphoteric and/or zwitterionic surfactant (e.g., betaine) or mixtures thereof (e.g., 0.1 to 25% by wt . ) ; (b) 0.1% to 15% by wt . , preferably 1% to 10% by wt . of a lamellar phase inducing structurant selected from the group consisting of :
(i) C8 to C24 unsaturated and/or branched liquid fatty acid or ester thereof; (ii) Cg to C24 unsaturated and/or branched liquid alcohol or ether thereof; and (iii) C5 to Cg saturated fatty acids; wherein the structurant has a melting point below about 25°C; (c) 0.1% to 5%, preferably 0.2% to 3%, more preferably 0.25% to 2% by wt . of a polymeric hydrophilic emulsifier modified on one or both ends," preferably both, with hydrophobic polyhydroxy fatty acid ester chains, (e.g., mono or dipolyhydroxy, Cg-C24 fatty acid esters, particularly dipolyhydroxy stearate) wherein the compositions have an initial viscosity of greater than, 40,000 cps measured at 0.5 RPM using T-bar spindle A, preferably greater than 75,000 cps, more preferably from about 90,000 to about 150,000 cps, and a freeze thaw viscosity (measured after at least one cycle, preferably at least 2 cycles, most preferably at 3 cycles of -9.4°C (15F) to room temperature freeze thaw cycles) at greater than about 40,000 cps, preferably greater than 50,000 (again measured at 0.5 RPM using T-bar spindle A) . Ideally, there should be no change in viscosity from initial viscosity, although this of course is not always possible .
Particularly preferred emulsifiers comprise a polyalkylene glycol backbone and have 1 to 50 hydroxy Cg to
C24 fatty acid groups attached to one or both sides of the backbone .
The invention will now be further described by way of example only, with reference to the accompanying figures, in which : Figure 1 shows effect of the polymeric hydrophilic emulsifier of invention when used in combination with lamellar phase inducing structurant. The emulsifier enhances both initial and freeze-thaw viscosity compared to use of structurant with no emulsifier.
Figure 2 shows that, for a given level of lamellar inducing structurant (e.g., isostearic acid at 5%), use of emulsifier (e.g., Arlacel P135) has no significant negative impact on lather production.
Figure 3A and 3B shows that, although it is possible to improve initial and freeze-thaw viscosity by increasing level of isostearic acid, for example, in combination with 0.5% Arlacel P135 (Figure 3A) , the additional isostearic acid added to constant small level of Arlacel P135 will negatively impact on lather volume (Figure 3B) . Therefore, to improve both stability without effecting lather volume, the focus should be on using emulsifier rather than increasing lamellar inducing structurant.
Figure 4 is a schematic structure of a typical polymeric emulsifier, PEG-30 dipolyhydroxystearate.
The present invention relates to liquid cleansing compositions, particularly lamellar structured liquid cleansing compositions comprising:
(a) 5% to 50% by wt . of a surfactant system comprising one or more anionic surfactants and preferably further comprising an amphoteric and/or zwitterionic surfactant or mixtures thereof; (b) 1% to 15% by wt . , preferably 1 to 10% by wt . of a lamellar phase inducing structurant which can be selected form the group consisting of:
(i) Cg to C24 unsaturated and/or branched liquid fatty acid or ester thereof;
(ii) C3 to C24 unsaturated and/or branched liquid alcohol or ether thereof; and
(iii) C5 to C9 saturated fatty acids; wherein the structurant has a melting point below about 25°C;
(c) 0.1% to 5% of a polymeric hydrophilic emulsifier modified on one or both ends, preferably both with hydrophobic polyhydroxy fatty acid ester chains,
(e.g., mono or dipolyhydroxy, C8-C2 fatty acid esters, such as, for example dipolyhydroxystearate) ; wherein the composition has an initial viscosity of greater than 40,000 cps, preferably 90,000 to 130,000 cps; and a freeze thaw viscosity of greater than 40,000 cps, preferably greater than
50,000 cps, wherein viscosity is measured at 0.5 RPM using T-bar spindle A.
The surfactant system of the subject invention comprises 5 to 50% by weight, preferably 10 to 40% by wt . of the composition and comprises : (a) one or more anionic surfactants;
(b) amphoteric and/or zwitterionic surfactant; and
(c) an optional nonionic surfactant
The anionic surfactant may be, for example, an aliphatic sulfonate, such as a primary alkane (e.g., C8-C22) sulfonate, primary alkane (e.g., C8-C 2) disulfonate, C8-C22 alkene sulfonate, C8-C22 hydroxyalkane sulfonate or alkyl glyceryl ether sulfonate (AGS) ; or an aromatic sulfonate such as alkyl benzene sulfonate.
The anionic may also be an alkyl sulfate (e.g., C^- ^ alkyl sulfate) or alkyl ether sulfate (including alkyl glyceryl ether sulfates) . Among the alkyl ether sulfates are those having the formula:
RO(CH2CH20)nS03M
wherein R is an alkyl or alkenyl having 8 to 18 carbons, preferably 12 to 18 carbons, n has an average value of greater than 1.0, preferably between 2 and 3; and M is a solubilizing cation such as sodium, potassium, ammonium or substituted ammonium. Ammonium and sodium lauryl ether sulfates are preferred.
The anionic may also be alkyl sulfosuccinates
(including mono- and dialkyl, e.g., Cg-C22 sulfosuccinates) ; alkyl and acyl taurates, alkyl and acyl sarcosinates, sulfoacetates, C8-C22 alkyl phosphates and phosphates, alkyl phosphate esters and alkoxyl alkyl phosphate esters, acyl lactates, C8-C22 monoalkyl succinates and maleates, " sulphoacetates, and acyl isethionates .
Sulfosuccinates may be monoalkyl sulfosuccinates having the formula:
R 02CCH2CH ( Sθ3M) Cθ2M ;
amido-MEA sulfosuccinates of the formula
R4CONHCH2CH2θ2CCH2CH ( S03M) C02M
4 wherein R ranges from C8-C22 alkyl and M is a solubilizing cation;
amido-MIPA sulfosuccinates of formula
RC0NH(CH2)CH(CH3) (S03M) C02M
where M is as defined above.
Also included are the alkoxylated citrate sulfosuccinates; and alkoxylated sulfosuccinates such as the following:
O
II
R-O- (CH2CH20) nCCH2CH (S03M) C02M wherein n = 1 to 20; and M is as defined above. " Sarcosinates are generally indicated by the formula RCON (CH3) CH2C02M, wherein R ranges from C8 to C20 alkyl and M is a solubilizing cation.
Taurates are generally identified by formula
R2CONR3CH2CH2S03M
2 3 wherein R ranges from C8-C o alkyl, R ranges from Ci-
C4 alkyl and M is a solubilizing cation.
Another class of anionics are carboxylates such as follows :
R- (CH2CH20)nC02M
wherein R is C8 to C20 alkyl; n is 0 to 20; and M is as defined above.
Another carboxylate which can be used is amido alkyl polypeptide carboxylates such as, for example, Monteine
LCQ(R) by Seppic.
Another surfactant which may be used are the C8-Cχ8 acyl isethionates . These esters are prepared by reaction between alkali metal isethionate with mixed aliphatic fatty acids having from 6 to 18 carbon atoms and an iodine value of less than 20. At least 75% of the mixed fatty acids have from 12 to 18 carbon atoms and up to 25% have from 6 to 10 carbon atoms .
Acyl isethionates, when present, will generally range from about 0.5-15% by weight of the total composition.
Preferably, this component is present from about 1 to about 10%.
The acyl isethionate may be an alkoxylated isethionate such as is described in Ilardi et al . , U.S. Patent No.
5,393,466, hereby incorporated by reference into the subject application. This compound has the general formula:
O X
R C-0-CH-CH2- (OCH-CH2)m- SO 3M
wherein R is an alkyl group having 8 to 18 carbons, m is an integer from 1 to 4, X and Y are hydrogen or an alkyl group having 1 to 4 carbons and M is a monovalent cation such as, for example, sodium, potassium or ammonium.
In general the anionic component will comprise from about 1 to 20% by weight of the composition, preferably 2 to 15%, most preferably 5 to 12% by weight of the composition.
Suitable zwitterionic surfactants are exemplified by those which can be broadly described as derivatives of aliphatic quaternary ammonium, phosphonium, and sulfonium compounds, in which the aliphatic radicals can be straight or branched chain, and wherein one of the aliphatic substituents contains from about 8 to about 18 carbon atoms and one contains an anionic group, e.g., carboxy, sulfonate, sulfate, phosphate, or phosphonate. A general formula for these compounds is:
(R3)χ I
R2-Y(+)-CH2-R4Z ) 2 wherein R contains an alkyl, alkenyl, or hydroxy alkyl radical of from about 8 to about 18 carbon atoms, from 0 to about 10 ethylene oxide moieties and from 0 to about 1 glyceryl moieties; Y is selected from nitrogen, phosphorus,
3 and sulfur atoms; R is an alkyl or monohydroxyalkyl group containing about 1 to about 3 carbon atoms; X is 1 when Y is a sulfur atom, and 2 when Y is a nitrogen or phosphorus
4 atom; R is an alkylene or hydroxyalkylene of from about 1 to about 4 carbon atoms and Z is a radical selected from carboxylate, sulfonate, sulfate, phosphonate, and phosphate groups .
Examples of such surfactants include: 4- [N,N-di (2 -hydroxyethyl) -N-octadecylammonio] -butane-1- carboxylate;
5- [S-3-hydroxypropyl-S-hexadecylsulfonio] -3- hydroxypentane- 1 -sulfate ;
3- [P, P-diethyl-P-3 , 6, 9-trioxatetradexocylphosphonio] -2- hydroxypropane-1-phosphate ;
3- [N,N-dipropyl-N-3-dodecoxy-2 -hydroxypropylammonio] - propane- 1 -phosphonate ;
3- (N, -dimethyl-N-hexadecylammonio) propane- 1 -sulfonate ; 3- (N, N-dimethyl-N-hexadecylammonio) -2 -hydroxypropane- 1- sulfonate;
4- [N,N-di (2 -hydroxyethyl) -N- (2-hydroxydodecyl) ammonio] - butane- 1 -carboxylate ; 3- [S-ethyl-S- (3-dodecoxy-2-hydroxypropyl) sulfonio] - propane- 1 -phosphate ;
3- [P, P-dimethyl-P-dodecylphosphonio] -propane-1- phosphonate; and 5- [N,N-di (3-hydroxypropyl) -N-hexadecylammonio] -2- hydroxy-pentane-1-sulfate .
Suitable amphoteric detergents which may be used in this invention include at least one acid group. This may be a carboxylic or a sulphonic acid group. They include quaternary nitrogen and therefore are quaternary amido acids. They should generally include an alkyl or alkenyl group of 7 to 18 carbon atoms. They will usually comply with an overall structural formula:
0 R ι R - [-C-NH(CH2)n-Jm-N+-X-Y
where R is alkyl or alkenyl of 7 to 18 carbon atoms;
2 3 R and R are each independently alkyl, hydroxyalkyl or carboxyalkyl of 1 to 3 carbon atoms;
n is 2 to 4;
m is 0 to 1;
X is alkylene of 1 to 3 carbon atoms optionally substituted with hydroxyl , and Y i s - C02 - or - S03 -
Suitable amphoteric detergents within the above general formula include simple betaines of formula:
R'
RJ -N -CH2C02
R" and amido betaines of formula:
R
R1 - C0NH(CH2)m N+ CH2C02 "
R"
where m is 2 or 3
1 2 3 In both formulae R , R and R are as defined previously. R may in particular be a mixture of C12 and C^ alkyl groups derived from coconut so that at least half, preferably at least three quarters of the groups R have 10
2 3 to 14 carbon atoms. R and R are preferably methyl.
A further possibility is that the amphoteric detergent is a sulphobetaine of formula: R'
R -N J CH2 ) 3S03 "
R" or
R
R1 - CONH (CH2)m—N+— (CH2)3S03 '
R"
where m is 2 or 3, or variants of these in which - (CH2)3SO 3 is replaced by
OH
I
-CH2CHCH2S03 "
1 2 3 In these formulae R , R and R are as discussed previously.
Amphoacetates and diamphoacetates are also intended to be covered in possible zwitterionic and/or amphoteric compounds which may be used.
The amphoteric/zwitterionic surfactant, when used, generally comprises 0% to 25%, preferably 0.1 to 20% by weight, preferably 5% to 15% of the composition. A preferred surfactant system of the invention comprises acyl isethionate in combination with betaine (e.g., cocoamido propylbetaine) .
The surfactant system may optionally comprise a nonionic surfactant .
The nonionic which may be used includes in particular the reaction products of compounds having a hydrophobic group and a reactive hydrogen atom, for example aliphatic alcohols, acids, amides or alkyl phenols with alkylene oxides, especially ethylene oxide either alone or with propylene oxide. Specific nonionic detergent compounds are alkyl (Cg-C22) phenols-ethylene oxide condensates, the condensation products of aliphatic (C8-C]_8) primary or secondary linear or branched alcohols with ethylene oxide, and products made by condensation of ethylene oxide with the reaction products of propylene oxide and ethylenediamine . Other so-called nonionic detergent compounds include long chain tertiary amine oxides, long chain tertiary phosphine oxides and dialkyl sulphoxides .
The nonionic may also be a sugar amide, such as a polysaccharide amide. Specifically, the surfactant may be one of the lactobionamides described in U.S. Patent No. 5,389,279 to Au et al . which is hereby incorporated by reference or it may be one of the sugar amides described in Patent No. 5,009,814 to Kelkenberg, hereby incorporated into the subject application by reference.
Other surfactants which may be used are described in U.S. Patent No. 3,723,325 to Parran Jr. and alkyl - I i
polysaccharide nonionic surfactants as disclosed in U.S. Patent No. 4,565,647 to Llenado, both of which are also incorporated into the subject application by reference.
Preferred alkyl polysaccharides are alkylpolyglycosides of the formula
R 0(CnH2nO)t(glycosyi: x
2 wherein R is selected from the group consisting of alkyl , alkylphenyl , hydroxyalkyl , hydroxyalkylphenyl , and mixtures thereof in which alkyl groups contain from about 10 to about 18, preferably from about 12 to about 14, carbon atoms; n is 0 to 3, preferably 2; t is from 0 to about 10, preferably 0; and x is from 1.3 to about 10, preferably from 1.3 to about 2.7. The glycosyl is preferably derived from glucose. To prepare these compounds, the alcohol or alkylpolyethoxy alcohol is formed first and then reacted with glucose, or a source of glucose, to form the glucoside (attachment at the 1-position) . The additional glycosyl units can then be attached between their 1 -position and the preceding glycosyl units 2-, 3-, 4- and/or 6 -position, preferably predominantly the 2 -position.
Nonionic surfactant typically comprises 0 to 10% by wt . of the composition.
The present invention provides compositions utilizing about 0.1% to 15% by wt . , preferably 1 to 10% by wt . of a structuring agent which works in the compositions to form a lamellar phase. Such lamellar phase is preferred because it enables the compositions to suspend particles more readily (e.g., emollient particles) while still maintaining good shear thinning properties. The lamellar phase also provides consumers with desired rheology ("heaping").
More particularly, where the composition is not lamellar structured and enhanced particle suspension/enhancing is desired, it is usually necessary to add external structurants such as carbomers (e.g., cross- linked polyacrylate such as Carbopol (R) ) and clays. However, these external structurants have poorer shear thinning properties that significantly reduce consumer acceptability.
The structurant is generally an unsaturated and/or branched long chain (C8-C24) liquid fatty acid or ester derivative thereof; and/or unsaturated and/or branched long chain liquid alcohol or ether derivatives thereof. It may also be a short chain saturated fatty acid such as capric acid or caprylic acid. While not wishing to be bound by theory, it is believed that the unsaturated part of the fatty acid of alcohol or the branched part of the fatty acid or alcohol acts to "disorder" the surfactant hydrophobic chains and induce formation of lamellar phase.
Examples of liquid fatty acids which may be used are oleic acid, isostearic acid, linoleic acid, linolenic acid, ricinoleic acid, elaidic acid, arichidonic acid, myristoleic acid and palmitoleic acid. Ester derivatives include propylene glycol isostearate, propylene glycol oleate, glyceryl isostearate, glyceryl oleate and polyglyceryl diisostearate . Examples of alcohols include oleyl alcohol and isostearyl alcohol . Examples of ether derivatives include isosteareth or oleth carboxylic acid; or isosteareth or oleth alcohol .
The structuring agent may be defined as having melting point below about 25°C centigrade.
The key to the invention is the discovery that use of relatively small amounts of hydrophilic emulsifier modified at one or both ends, preferably both ends, with hydrophobic polyhydroxy fatty acid ester chains can remarkably enhance both initial viscosity/stability as well as freeze-thaw stability of the composition. Further, it does so without sacrificing lather production. Thus, as demonstrated in the examples, use of as little as 0.1%, preferably 0.25% of the emulsifier enhances viscosity of the composition relative to compositions which contain lamellar inducing structurant, but do not additionally contain the emulsifier.
The emulsifier may comprise a polyalkylene glycol backbone chain (e.g., H (OCH2CH2) n0H) wherein n ranges from 2 to 60. Preferably, the polyalkylene glycol backbone unit is a C2-C4 alkylene glycol such as ethylene or propylene glycol.
One or both ends, preferably both, of the polyalkylene glycol backbone are modified with attached polyhydroxy fatty acid C8 to C2 , preferably C12 to C20 esters such as, for example, polyhydroxystearate . If the group is stearate, for example, the hydrophobic group might be as follows: [CH3 ( CH2 ) 5CH ( CH2 ) I OCOOH] ± ;
I OH
wherein i may vary from 1 to 50.
Figure 4 provides a schematic structure of a typical emulsifier which might be used having a polyalkylene glycol backbone as noted above and modified at both ends with hydrophobic groups (e.g., polyhydroxystearate) wherein number of groups at each end could vary from 1 to 50.
One example such an emulsifier which serves particularly well in the subject invention is PEG-30 dipolyhydroxystearate which is also known under the tradename Arlacel P135 (R) ex ICI . As noted, the number of repeating alkylene groups on the chain could vary from 2 to 60 and attached hydrophobic groups may be other polyhydroxy fatty acid esters, wherein the number of groups at each end varies from 1 to 50.
A particularly good combination of the invention providing enhanced initial and freeze-thaw viscosity comprises use of isostearic acid in combination with PEG-30 dipolyhydroxystearate.
When isostearic acid alone, for example, is used as lamellar inducing structurant, the initial viscosity is about 40,000 cps, but when subjected to freeze-thaw tests when temperature is lowered (i.e., to be about -9.4°C(15F)) and raised (i.e., to room temperature), the viscosity remains the same or lower. When even small amounts of emulsifier are used, however (e.g., 0.25%), both initial viscosity and freeze- thaw viscosity are enhanced.
One of the principle benefits of the invention is the ability to suspend oil/emollient particles in a lamellar phase composition. The following oils/emollients may optionally be suspended in the compositions of the invention. Various classes of oils are set forth below.
Vegetable oils: Arachis oil, castor oil, cocoa butter, coconut oil, corn oil, cotton seed oil, olive oil, palm kernel oil, rapeseed oil, safflower seed oil, sesame seed oil and soybean oil .
Esters: Butyl myristate, cetyl palmitate, decyloleate, glyceryl laurate, glyceryl ricinoleate, glyceryl stearate, glyceryl isostearate, hexyl laurate, isobutyl palmitate, isocetyl stearate, isopropyl isostearate, isopropyl laurate, isopropyl linoleate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, propylene glycol monolaurate, propylene glycol ricinoleate, propylene glycol stearate, and propylene glycol isostearate.
Animal Fats: Acytylatelte lanolin alcohols, lanolin, lard, mink oil and tallow.
Fatty acids and alcohols: Behenic acid, palmitic acid, stearic acid, behenyl alcohol, cetyl alcohol, eicosanyl alcohol and isocetyl alcohol. Other examples of oils/emollients include mineral oil, petrolatum, silicone oil such as dimethyl polysiloxane, lauryl and myristyl lactate.
It should be understood that where the emollient may also function as a structurant, it should not be doubly included such that, for example, if the structurant is 15% oleyl alcohol, no more than 5% oleyl alcohol as "emollient" would be added since the emollient (whether functioning as emollient or structurant) never comprises more than 20%, preferably no more than 15% of the composition.
The emollient/oil is generally used in an amount from about 1 to 20%, preferably 1 to 15% by wt . of the composition. Generally, it should comprise no more than 20% of the composition.
In addition, the compositions of the invention may include optional ingredients as follows:
Organic solvents, such as ethanol ; auxiliary thickeners, such as carboxymethylcellulose, magnesium aluminum silicate, hydroxyethylcellulose, methylcellulose, carbopols, glucamides, or Antil (R) from Rhone Poulenc; perfumes; sequestering agents, such as tetrasodium ethylenediaminetetraacetate (EDTA) , EHDP or mixtures in an amount of 0.01 to 1%, preferably 0.01 to 0.05%; and coloring agents, opacifiers and pearlizers such as zinc stearate, magnesium stearate, Ti02, EGMS (ethylene glycol monostearate) or Lytron 621 (Styrene/Acrylate copolymer) ; all of which are useful in enhancing the appearance or cosmetic properties of the product. The compositions may further comprise antimicrobials such as 2-hydroxy-4 , 2 ' 4 ' trichlorodiphenylether (DP300) ; preservatives such as dimethyloldimethylhydantoin (Glydant XL1000™) , parabens, sorbic acid, and so on.
The compositions may also comprise coconut acyl mono- or diethanol amides as suds boosters, and strongly ionizing salts such as sodium chloride and sodium sulfate may also be used to advantage.
Antioxidants such as, for example, butylated hydroxytoluene (BHT) may be used advantageously in amounts of about 0.01% or higher if appropriate.
Cationic conditioners which may be used include Quatrisoft LM-200 Polyquaternium-24 , Merquat Plus 3330 Polyquaternium 39; and Jaguar (R) type conditioners.
Polyethylene glycols which may be used include:
Polyox WSR-205 PEG 14M, Polyox WSR-N-60K PEG 45M, or Polyox WSR-N-750 PEG 7M.
Thickeners which may be used include Amerchol Polymer
HM 1500 (Nonoxynyl Hydroethyl Cellulose) ; Glucam DOE 120 (PEG 120 Methyl Glucose Dioleate) ; Rewoderm (R) (PEG modified glyceryl cocoate, palmate or tallowate) from Rewo Chemicals; Antil(R) 141 (from Goldschmidt) . Another optional ingredient which may be added are the deflocculating polymers such as are taught in U.S. Patent No. 5,147,576 to Montague, hereby incorporated by reference.
Another ingredient which may be included are exfoliants such as polyoxyethylene beads, walnut sheets and apricot seeds
The invention will now be described in greater detail by way of the following non-limiting examples. The examples are for illustrative purposes only and not intended to limit the invention in any way. All percentages in the specification and examples are intended to be by weight unless stated otherwise.
EXAMPLES
Tests relating to use of polymeric emulsifier in lamellar structured shower gel compositions where conducted in the following base compositions:
Base
Viscosity measurements were made in accordance with the following protocol .
This method covers the measurement of the viscosity of the finished product. It is used to measure the degree of structuring of the product .
Apparatus :
Brookfield RVT Viscometer with Helipath Accessory;
Chuck, weight and closer assembly for T-bar attachment;
T-bar Spindle A;
Plastic cups diameter greater than 6.35cm (2.5 inches).
Procedure:
Verify that the viscometer and the helipath stand are level by referring to the bubble levels on the back of the instrument .
Connect the chuck/closer/weight assembly to the Viscometer (Note the left-hand coupling threads) .
3. Clean Spindle A with deionized water and pat dry with a Kimwipe sheet. Slide the spindle in the closer and tighten.
4. Set the rotational speed at 0.5 RPM. In case of a digital viscometer (DV) select the % mode and press autozero with the motor switch on.
5. Place the product in a plastic cup with inner diameter of greater than 6.35cm (2.5 inches) . The height of the product in the cup should be at least 7.6cm (3 inches) . The temperature of the product should be 25°C.
6. Lower the spindle into the product (~6.4mm (1/4 inches) ) . Set the adjustable stops of the helipath stand so that the spindle does not touch the bottom of the plastic cup or come out of the sample.
7. Start the viscometer and allow the dial to make one or two revolutions before turning on the helipath stand.
Note the dial reading as the helipath stand passes the middle of its downward traverse.
8. Multiply the dial dreading by a factor of 4,000 and report the viscosity reading in cps.
EXAMPLE 1
Using the base noted above, the applicants prepared compositions comprising base, oil, Arlacel P135 and isostearic acid as noted below and obtained viscosity results at both normal (room temperature) and accelerated conditions as follows:
As can be seen from the data, when no Arlacel P135 was used (Comparatives A, B, C and D) , both initial viscosity and freeze-thaw viscosity were significantly lower compared to use of small amounts of Arlacel (A versus 1 & 2 ; B versus 3 , C versus 4 , and D versus 5 ) .
As noted, this was true no matter which oil was used.
EXAMPLE 2
Again using a composition noted above, the applicants tested for both initial and low temperature viscosity enhancement in compositions comprising varying levels of active (PEG-30 dipolyhydroxystearate) and isostearic acid. Either levels of emulsifier or lamellar inducing structurant can be varied although preferably it is level of emulsifier which is varied to ensure foam volume is maintained.
As noted in Figure 1, use of even low levels of dipolyhydroxystearate resulted in significant improvements in both initial and freeze-thaw viscosity compared to use of isostearic acid alone where viscosity remained low and certainly was not enhanced following freeze-thaw treatment.
It should be noted that 40,000 cps (seen in Figure 1 as a dotted line) is minimum target for acceptable rheology and aesthetic pleasing according to the subject invention.
EXAMPLE 3
Applicants tested effect of isostearic acid versus Arlacel P135 as shown in Figure 2. This figure shows that, at given levels lamellar inducing structurant (5% isostearic acid) , use of emulsifier has no significant negative effect on lather.
EXAMPLE 4 (Comparative)
To show that Arlacel was providing significant effect, applicants tested known products that are lamellar structured for freeze-thaw stability after 3 cycles. Data is shown below.
As clearly seen, in the absence of Arlacel P135, the viscosities were significantly lower than initial viscosity as well as below the 40,000 cps viscosity target required for the compositions of the subject invention (i.e., to provide good rheology and aesthetically pleasing properties) .
EXAMPLE 5
Although initial viscosity and freeze-thaw viscosity can be improved by addition of lamellar inducing structurant (e.g. isostearic acid), in combination with polyethylene glycol for example, (Figure 3A) , if it is added to a constant small level of emulsifier, lather volume is effected (Figure 3B) .
Thus, in preferred embodiments of invention, focus is on using more emulsifier rather than just increasing lamellar inducing structurant.

Claims

1. A liquid cleansing composition comprising:
(a) 5% to 50% by wt . of a surfactant system comprising:
(i) 0.5 to 25% by wt . total composition of at least one anionic or mixture of anionic surfactants; and
(ii) 0.1 to 25% by wt . total composition of a surfactant selected from amphoteric, zwitterionic or mixtures thereof;
(b) 0.1% to 15% by wt . of a lamellar phase inducing structurant selected from:
(i) CQ to C24 unsaturated and/or branched liquid fatty acid or ester thereof;
(ii) C8 to C24 unsaturated and/or branched liquid alcohol or ether thereof; and
(iii) C5 to Cg saturated fatty acids; wherein the structurant has a melting point below 25┬░C;
(c) 0.1% to 5% by wt . of a polymeric hydrophilic emulsifier modified at one or both ends with hydrophobic polyhydroxy fatty acid ester chain; wherein the composition has an initial viscosity of greater than 40,000 cps, measured at 0.5 RPM using T-bar spindle A; and freeze-thaw viscosity of greater than about 40,000 cps also measured at 0.5 RPM using T-bar spindle A.
2. A composition according to claim 1, wherein anionic is acyl isethionate.
3. A composition according to claim 1 or 2 , wherein (a) (ii) is an amphoteric surfactant which is betaine.
4. A composition according to any of claims 1 to 3 , wherein the structurant is isostearic acid.
5. A composition according to any of claims 1 to 4 , wherein the emulsifier is dipolyhydroxy C 2- 24 fatty acid ester.
6. A composition according to claim 5, wherein the emulsifier is dipolyhydroxystearate.
7. A composition according to any of claims 1 to 4 , wherein the emulsifier is a polyalkylene glycol backbone chain of general formula:
H(0(CH2)a)nOH wherein a is 2 to 4 and n is 2 to 60 having 1 to 50 C8 to C24 fatty acid group or groups attached to one or both sides of the backbone.
8. A composition according to claim 7, wherein the fatty acid group or groups attached to backbone chain is hydrostearic acid.
9. A composition according to any of claims 1 to 8 , wherein initial viscosity is greater than 75,000 cps.
10. A composition according to claim 9, wherein initial viscosity is 90,000 to 135,000 cps.
11. Use of a polymeric hydrophilic emulsifier modified at one or both ends with hydrophobic polyhydroxy fatty acid ester chain for the purpose of enhancing the initial viscosity and/or the low temperature viscosity of a liquid cleansing composition comprising;
(a) 5% to 50% by wt . of a surfactant system comprising:
(i) 0.5 to 25% by wt . total composition of at least one anionic or mixture of anionic surfactants; and
(ii) 0.1 to 25% by wt . total composition of a surfactant selected from amphoteric, zwitterionic or mixtures thereof;
(b) 0.1% to 15% by wt . of a lamellar phase inducing structurant selected from:
(i) Cg to C24 unsaturated and/or branched liquid fatty acid or ester thereof; (ii) Cg to C24 unsaturated and/or branched liquid alcohol or ether thereof; and (iii) C5 to C9 saturated fatty acids; wherein the structurant has a melting point below 25┬░C.
EP98966317A 1997-12-18 1998-12-08 Liquid composition with enhanced low temperature stability Expired - Lifetime EP1037601B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US993497 1997-12-18
US08/993,497 US6174846B1 (en) 1997-12-18 1997-12-18 Liquid composition with enhanced low temperature stability
PCT/EP1998/008146 WO1999032069A2 (en) 1997-12-18 1998-12-08 Liquid composition with enhanced low temperature stability

Publications (2)

Publication Number Publication Date
EP1037601A2 true EP1037601A2 (en) 2000-09-27
EP1037601B1 EP1037601B1 (en) 2003-05-02

Family

ID=25539617

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98966317A Expired - Lifetime EP1037601B1 (en) 1997-12-18 1998-12-08 Liquid composition with enhanced low temperature stability

Country Status (16)

Country Link
US (1) US6174846B1 (en)
EP (1) EP1037601B1 (en)
JP (1) JP4056221B2 (en)
KR (1) KR20010033197A (en)
CN (1) CN1178646C (en)
AU (1) AU2271999A (en)
CA (1) CA2315002C (en)
CZ (1) CZ299188B6 (en)
DE (1) DE69814150T2 (en)
ES (1) ES2198790T3 (en)
HK (1) HK1031338A1 (en)
HU (1) HUP0100099A3 (en)
IN (1) IN190695B (en)
PL (1) PL342363A1 (en)
WO (1) WO1999032069A2 (en)
ZA (1) ZA9811518B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008035172A1 (en) 2008-07-28 2010-02-04 Henkel Ag & Co. Kgaa Structured composition with optimal storage stability properties

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150312A (en) * 1999-04-05 2000-11-21 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Liquid composition with enhanced low temperature stability comprising sodium tricedeth sulfate
US6426326B1 (en) * 1999-09-16 2002-07-30 Unilever Home & Person Care Usa, A Division Of Conopco, Inc. Liquid cleansing composition comprising lamellar phase inducing structurant with low salt content and enhanced low temperature stability
US6534457B2 (en) 2000-03-20 2003-03-18 Unilever Home And Personal Care Usa, Division Of Conopco, Inc. Extrudable multiphase composition comprising lamellar phase inducing structurant in each phase
MXPA03007766A (en) * 2001-02-28 2004-03-16 Akzo Nobel Nv Injectable water-in-oil emulsions.
AU2002314847A1 (en) 2001-05-31 2002-12-09 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
ES2298438T3 (en) * 2001-12-21 2008-05-16 Rhodia Inc. COMBINED STABLE COMPOSITIONS OF CATIONIC AND ANIONIC TENSIANS.
JP2005515215A (en) 2001-12-21 2005-05-26 ローディア インコーポレイティド Stable surfactant composition for suspending ingredients
EP1670426A4 (en) * 2003-07-22 2009-12-09 Rhodia New branched sulfates for use in personal care formulations
RU2006123412A (en) * 2003-12-03 2008-01-10 Родиа Инк. (Us) BRANCHED SULPHATES WITH IMPROVED AROMATIC PROPERTIES AND THEIR APPLICATION IN COMPOSITIONS INTENDED FOR PERSONAL HYGIENE
JP2007532765A (en) * 2004-04-15 2007-11-15 ローディア インコーポレイティド Structured surfactant composition
US20050265936A1 (en) * 2004-05-25 2005-12-01 Knopf Michael A Cleansing foaming sunscreen lotion
US20050025731A1 (en) * 2004-05-25 2005-02-03 Knopf Michael A. Cleansing foaming lotion
US20060008434A1 (en) * 2004-05-25 2006-01-12 Knopf Michael A Deodorant body wash with lotion
US20060135627A1 (en) * 2004-08-17 2006-06-22 Seren Frantz Structured surfactant compositions
CA2577460C (en) * 2004-08-17 2013-05-14 Rhodia, Inc. Low ph structured surfactant compositions
KR101210126B1 (en) * 2004-08-19 2012-12-07 콜게이트-파아므올리브캄파니 Enhanced oil delivery from structured surfactant formulations
EP1882029B1 (en) * 2005-05-20 2014-05-07 Solvay USA Inc. Structured surfactant compositions
WO2008006058A2 (en) * 2006-07-06 2008-01-10 Stepan Company Alkyl lactyllactate solvent compositions
US7671000B2 (en) 2006-12-20 2010-03-02 Conopco, Inc. Stable liquid cleansing compositions comprising fatty acyl isethionate surfactant products with high fatty acid content
US7655607B2 (en) 2006-12-20 2010-02-02 Conopco, Inc. Method of providing stability for liquid cleansing compositions comprising selection fatty acyl isethionate surfactants
US7659235B2 (en) * 2006-12-20 2010-02-09 Conopco, Inc. Stable liquid cleansing compositions which may be prepared using fatty acyl isethionate surfactants
US8828364B2 (en) * 2007-03-23 2014-09-09 Rhodia Operations Structured surfactant compositions
US20090005460A1 (en) * 2007-06-29 2009-01-01 Gunn Euen T Methods of making and using structured compositions comprising betaine
US8518991B2 (en) * 2007-06-29 2013-08-27 Johnson & Johnson Consumer Companies, Inc. Structured compositions comprising betaine
US8623344B2 (en) * 2007-06-29 2014-01-07 Mcneil-Ppc, Inc. Structured depilatory compositions
US7674759B2 (en) 2007-09-05 2010-03-09 Conopco, Inc. Stable liquid cleansing compositions containing high level of fatty acid isethionate surfactant products having more than 10 wt. % of fatty acid/fatty soap content
GB0722550D0 (en) * 2007-11-16 2007-12-27 Innospec Ltd Composition
US7807612B2 (en) 2007-12-18 2010-10-05 Conopco, Inc. Fatty acyl isethionate product-containing liquid cleansing compositions stabilized with mixture of long chain and short chain fatty acids/fatty soaps
JP5256749B2 (en) * 2008-01-23 2013-08-07 住友化学株式会社 Emulsion composition
JP2009173578A (en) * 2008-01-24 2009-08-06 Sumitomo Chemical Co Ltd Emulsion composition
US7879780B2 (en) 2008-09-23 2011-02-01 Conopco, Inc. Stable cleansing compositions containing fatty acyl isethionate surfactant products having more than 10 wt. % of fatty acid/fatty soap content using high level of polyol and methods thereof
EP2216010A1 (en) 2009-02-05 2010-08-11 Rhodia Opérations Aqueous composition suitable as shampoo
US7879781B2 (en) * 2009-05-13 2011-02-01 Conopco, Inc. High emollient lamellar compositions resistant to viscosity and phase structure deterioration after low temp storage and/or freeze-thaw cycle
JP5548417B2 (en) * 2009-09-29 2014-07-16 ポーラ化成工業株式会社 Cleansing cosmetics
US8124574B2 (en) 2009-10-12 2012-02-28 Conopco, Inc. Mild, foaming liquid cleansers comprising low levels of fatty isethionate product and low total fatty acid and/or fatty acid soap content
US20110142965A1 (en) * 2009-12-10 2011-06-16 Bob Walke Skin moisturizer and washing formulation
US8263538B2 (en) 2010-03-31 2012-09-11 Conopco, Inc. Personal wash cleanser with mild surfactant systems comprising defined alkanoyl compounds and defined fatty acyl isethionate surfactant product
US8268767B2 (en) 2010-03-31 2012-09-18 Conopco, Inc. Personal wash cleanser comprising defined alkanoyl compounds, defined fatty acyl isethionate surfactant product and skin or hair benefit agent
US8105994B2 (en) 2010-03-31 2012-01-31 Conopco, Inc. Personal wash cleanser comprising defined alkanoyl compounds, defined fatty acyl isethionate surfactant product and skin or hair benefit agent delivered in flocs upon dilution
EA023762B1 (en) 2010-08-18 2016-07-29 Юнилевер Н.В. Anti-dandruff shampoo
US8722604B2 (en) * 2010-10-14 2014-05-13 Conopco, Inc. Stable liquid cleansing compositions comprising critical window of partially hydrogenated triglyceride oil of defined iodine value
US8846592B2 (en) * 2010-10-14 2014-09-30 Conopco, Inc. Stable liquid cleansing compositions comprising critical window of hydrogenated triglyceride oils
CN102028628B (en) * 2010-11-22 2012-09-12 苏州元素集化学工业有限公司 Thick cleaning composition
CN102204873B (en) * 2011-03-15 2014-02-12 苏州元素集化学工业有限公司 Thick cleaning composition
US9428715B2 (en) 2011-11-07 2016-08-30 The Nisshin Oillio Group, Ltd. Composition for cleansing agent and cleansing agent
BR112015014947A2 (en) 2012-12-21 2017-07-11 Rhodia Operations ph-responsive copolymer compositions containing maep and / or mahp and methods of using them
CN110305265A (en) 2012-12-21 2019-10-08 罗地亚经营管理公司 Anti-settling and thickener composition and the method for using it
EP3165216A1 (en) * 2015-11-05 2017-05-10 Basf Se Textured composition

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3957970A (en) * 1974-06-06 1976-05-18 American Cyanamid Company Improved shampoo containing an ester of polyethylene glycol, urea or thiourea and a polysiloxane
US5308526A (en) 1992-07-07 1994-05-03 The Procter & Gamble Company Liquid personal cleanser with moisturizer
GB9216854D0 (en) * 1992-08-07 1992-09-23 Unilever Plc Detergent composition
GB9216758D0 (en) * 1992-08-07 1992-09-23 Unilever Plc Detergent composition
GB9301295D0 (en) 1993-01-23 1993-03-17 Procter & Gamble Cleansing compositions
US5681802A (en) * 1994-06-01 1997-10-28 Lever Brothers Company, Division Of Conopco, Inc. Mild antimicrobial liquid cleansing formulations comprising buffering compound or compounds as potentiator of antimicrobial effectiveness
GB9414572D0 (en) 1994-07-19 1994-09-07 Unilever Plc Soap composition
CZ54797A3 (en) * 1994-08-26 1997-08-13 Procter & Gamble Preparation for personal cleanup
ES2125672T3 (en) * 1994-11-09 1999-03-01 Procter & Gamble CLEANSING TISUS TREATED WITH A WATER EMULSION IN LIPID.
CN1134251C (en) 1995-08-07 2004-01-14 尤尼利弗公司 Liquid cleansing composition comprising soluble, lamellar phase inducing structurant
US5683683A (en) * 1995-09-21 1997-11-04 Helene Curtis, Inc. Body wash composition to impart conditioning properties to skin
AU1720897A (en) 1996-02-15 1997-09-02 Unilever Plc Liquid cleansing compositions comprising select cationic polymers
US5792739A (en) * 1996-04-24 1998-08-11 Lever Brothers Company, Division Of Conopco, Inc. Liquid compositions comprising hydrophobically modified polyalkylene glycols as mildness actives
US5763332A (en) * 1996-04-30 1998-06-09 The Procter & Gamble Company Cleaning articles comprising a polarphobic region and a high internal phase inverse emulsion
CA2263981A1 (en) 1996-09-24 1998-04-02 Unilever Plc Liquid compositions comprising stability enhancing surfactants and a method of enhancing low temperature stability thereof
US5736125A (en) * 1997-01-10 1998-04-07 National Starch And Chemical Investment Holding Corporation Compositions containing copolymers as a thickening agent

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9932069A2 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008035172A1 (en) 2008-07-28 2010-02-04 Henkel Ag & Co. Kgaa Structured composition with optimal storage stability properties
WO2010012582A2 (en) 2008-07-28 2010-02-04 Henkel Ag & Co. Kgaa Structured composition with optimum storage stability properties

Also Published As

Publication number Publication date
EP1037601B1 (en) 2003-05-02
JP2001526197A (en) 2001-12-18
CZ20002271A3 (en) 2000-11-15
ZA9811518B (en) 2000-06-15
WO1999032069A2 (en) 1999-07-01
PL342363A1 (en) 2001-06-04
HUP0100099A2 (en) 2001-05-28
CN1284857A (en) 2001-02-21
CA2315002C (en) 2007-06-26
CZ299188B6 (en) 2008-05-14
DE69814150T2 (en) 2004-01-22
US6174846B1 (en) 2001-01-16
AU2271999A (en) 1999-07-12
HK1031338A1 (en) 2001-06-15
KR20010033197A (en) 2001-04-25
CA2315002A1 (en) 1999-07-01
CN1178646C (en) 2004-12-08
IN190695B (en) 2003-08-16
ES2198790T3 (en) 2004-02-01
HUP0100099A3 (en) 2001-06-28
WO1999032069A3 (en) 1999-09-10
DE69814150D1 (en) 2003-06-05
JP4056221B2 (en) 2008-03-05

Similar Documents

Publication Publication Date Title
EP1037601B1 (en) Liquid composition with enhanced low temperature stability
EP1165019B1 (en) Liquid composition with enhanced low temperature stability
EP1220886B1 (en) Liquid cleansing composition comprising lamellar phase having low salt level
EP0839023B1 (en) Liquid cleansing composition comprising soluble, lamellar phase inducing structurant
US6077816A (en) Liquid cleansing composition comprising soluble, lamellar phase inducing structurant
EP1607471B2 (en) Extrudable multiphase composition comprising lamellar phase inducing structurant in each phase
US6534456B2 (en) Extrudable multiphase composition comprising a lamellar phase and an isotropic phase
AU2001244180A1 (en) Extrudable multiphase composition comprising a lamellar phase and an isotropic phase
WO1998013022A1 (en) Liquid compositions comprising stability enhancing surfactants and a method of enhancing low temperature stability thereof
KR20000048538A (en) Liquid compositions comprising stability enhancing surfactants and a method of enhancing low temperature stability thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000523

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): DE ES FR GB IT

RIN1 Information on inventor provided before grant (corrected)

Inventor name: VILLA, VIRGILIO BABRA

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: UNILEVER N.V.

Owner name: UNILEVER PLC

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: UNILEVER N.V.

Owner name: UNILEVER PLC

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Designated state(s): DE ES FR GB IT

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 69814150

Country of ref document: DE

Date of ref document: 20030605

Kind code of ref document: P

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2198790

Country of ref document: ES

Kind code of ref document: T3

ET Fr: translation filed
PLBI Opposition filed

Free format text: ORIGINAL CODE: 0009260

PLBQ Unpublished change to opponent data

Free format text: ORIGINAL CODE: EPIDOS OPPO

PLAX Notice of opposition and request to file observation + time limit sent

Free format text: ORIGINAL CODE: EPIDOSNOBS2

26 Opposition filed

Opponent name: HENKEL KGAA

Effective date: 20040202

PLBB Reply of patent proprietor to notice(s) of opposition received

Free format text: ORIGINAL CODE: EPIDOSNOBS3

PLAB Opposition data, opponent's data or that of the opponent's representative modified

Free format text: ORIGINAL CODE: 0009299OPPO

R26 Opposition filed (corrected)

Opponent name: HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN

Effective date: 20040202

PLCK Communication despatched that opposition was rejected

Free format text: ORIGINAL CODE: EPIDOSNREJ1

PLBN Opposition rejected

Free format text: ORIGINAL CODE: 0009273

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: OPPOSITION REJECTED

27O Opposition rejected

Effective date: 20070214

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 18

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20161213

Year of fee payment: 19

Ref country code: GB

Payment date: 20161222

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20161222

Year of fee payment: 19

Ref country code: ES

Payment date: 20161213

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20161227

Year of fee payment: 19

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 69814150

Country of ref document: DE

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20171208

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20180831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180703

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180102

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171208

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171208

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20190702

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171209